Physician profile

Prashant Vaishnava

Cardiovascular Disease · New York, NY

NPI 1942351465

$1,455.45

in general payments reported to CMS, 2019-2025

16 companies · $167 in 2025

The $167 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$1,179.69

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Boehringer Ingelheim Pharmaceuticals, INC. $340.87 2023-2025 Jardiance
E.R. Squibb & Sons, L.L.C. $187.73 2022-2025 Camzyos, Eliquis
Vifor (International) LTD. $160.00 2020
Novartis Pharmaceuticals Corporation $139.27 2023-2024
Bayer Healthcare Pharmaceuticals INC. $125.00 2023
Janssen Pharmaceuticals, INC $93.79 2021-2024 Xarelto
Abbott Laboratories $80.59 2025 Cardiomems
Irhythm Technologies, INC. $79.15 2024 Zio Xt Patch, Zio Monitor
Boston Scientific Corporation $72.04 2020-2024 Watchman Flx
Medicomp INC $33.76 2025 Telepatch Cardiac Monitor
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $25.95 2023 Lifevest
Pfizer INC. $25.22 2023
Merck Sharp & Dohme LLC $24.13 2024 Verquvo
Lexicon Pharmaceuticals, INC. $23.35 2024 Inpefa
Alnylam Pharmaceuticals INC. $22.79 2022
Show all 16 companies
CompanyGeneral paymentsYearsTop products
Lilly USA, LLC $21.81 2023 Taltz

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Prashant Vaishnava

$1,455.45

in general payments reported 2019-2025

Years
2020-2025
Top company
Boehringer Ingelheim Pharmaceuticals, INC.
Context
The $167 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).

https://glasscript.com/doctor/560722/prashant-vaishnava

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.